Introduction

Jeff Meacham: Could this drug be the first $100 billion drug in the pharma industry? Jack Howe: Respira has changed its name to Qnovia, run by a former tobacco executive with vape experience. He'll also explain why he upgraded Merck and downgraded Pfizer; share his top big pharma stock picks right now.